SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-244686
Filing Date
2021-08-12
Accepted
2021-08-12 16:13:19
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d201063d10q.htm   iXBRL 10-Q 1665139
2 EX-10.1 d201063dex101.htm EX-10.1 193529
3 EX-31.1 d201063dex311.htm EX-31.1 10625
4 EX-31.2 d201063dex312.htm EX-31.2 10609
5 EX-32.1 d201063dex321.htm EX-32.1 6346
  Complete submission text file 0001193125-21-244686.txt   4782403

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmpi-20210630.xsd EX-101.SCH 29238
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpi-20210630_cal.xml EX-101.CAL 27260
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpi-20210630_def.xml EX-101.DEF 169706
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpi-20210630_lab.xml EX-101.LAB 245073
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpi-20210630_pre.xml EX-101.PRE 208174
11 EXTRACTED XBRL INSTANCE DOCUMENT d201063d10q_htm.xml XML 491539
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39425 | Film No.: 211167692
SIC: 2836 Biological Products, (No Diagnostic Substances)